Skip to main content
SpringerLink
Log in

Dietary Sodium: Where Science and Policy Conflict: Impact of the 2013 IOM Report on Sodium Intake in Populations

  • Invited Commentary
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

The 2013 Institute of Medicine (IOM) report “Sodium Intake in Populations: Assessment of Evidence” did not support the current recommendations of the IOM and the American Heart Association (AHA) to reduce daily dietary sodium intake to below 2300 mg. The report concluded that the population-based health outcome evidence was not sufficient to define a safe upper intake level for sodium. Recent studies have extended this conclusion to show that a sodium intake below 2300 mg/day is associated with increased mortality. In spite of this increasing body of evidence, the AHA, Centers for Disease Control (CDC), other public health advisory bodies, and major medical journals have continued to support the current policy of reducing dietary sodium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. IOM. (Institute of Medicine). Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academies Press; 2005.

  2. IOM. (Institute of Medicine). Dietary reference intakes: essential guide to nutrient requirements. Washington, DC: National Academies Press; 2006.

  3. IOM. (Institute of Medicine). Sodium intake in populations: assessment of evidence. Washington, DC: National Academies Press; 2013.

  4. Gunn JP, Barron JL, Bowman BA, Merritt RK, Cogswell ME, Angell SY, et al. Sodium reduction is a public health priority: reflections on the Institute of Medicine’s report, sodium intake in populations: assessment of evidence. AJH. 2013;26:1178–80.

    PubMed  Google Scholar 

  5. Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014;129:1173–86.

    Article  CAS  PubMed  Google Scholar 

  6. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880–9.

    Article  CAS  PubMed  Google Scholar 

  7. Pfister R, Michels G, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. Eur J Heart Fail. 2014 Jan 20. doi:10.1002/ejhf.56. [Epub ahead of print].

  8. Graudal N, Jürgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014;27:1129–37.

    Article  PubMed  Google Scholar 

  9. O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612–23.

    Article  PubMed  Google Scholar 

  10. Graudal NA, Galløe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols. JAMA. 1998;279:1383–91.

    Article  CAS  PubMed  Google Scholar 

  11. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2011;11, CD004022.

    PubMed  Google Scholar 

  12. Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11, CD002003.

    PubMed  Google Scholar 

  13. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Am J Hypertens. 2011;24:843–53.

    Article  CAS  PubMed  Google Scholar 

  14. Mente A, O’Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11.

    Article  CAS  PubMed  Google Scholar 

  15. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441–9.

    Article  CAS  PubMed  Google Scholar 

  16. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.

    Article  PubMed  Google Scholar 

  18. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38.

    PubMed  Google Scholar 

  20. The Trials of Hypertension Prevention Collaborative Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. JAMA. 1992;267:1213–20.

    Article  Google Scholar 

  21. The Trials of Hypertension Prevention Collaborative Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention Phase II. Arch Intern Med. 1997;157:657–67.

    Article  Google Scholar 

  22. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH–Sodium Collaborative Research Group. NEJM. 2001;344:3–10.

    Article  CAS  PubMed  Google Scholar 

  23. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001;161:685–93.

    Article  CAS  PubMed  Google Scholar 

  24. He F, MacGregor G. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–70.

    Article  CAS  PubMed  Google Scholar 

  25. Wright JD, Hughes JP, Ostchega Y, Yoon SS, Nwankwo T. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States; 2001–2008. National Health Statistics Report; 35: 1–24.

  26. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011;378:380–2.

    Article  PubMed  Google Scholar 

  27. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–34.

    Article  CAS  PubMed  Google Scholar 

  28. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2011;171:1183–91.

  29. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ. 1996;312:1249–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Kaiser J. Industry groups petition for data on salt and hypertension. Science. 2003;300:1350.

  31. Graudal N. Sodium and cardiovascular disease. N Engl J Med. 2014;371:2136–7.

Download references

Author information

Authors and Affiliations

  1. Department IR4242, Copenhagen University Hospital, “Rigshospitalet”, Blegdamsvej 9, 2100, Copenhagen, Denmark

    Niels Graudal

Authors
  1. Niels Graudal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niels Graudal.

Additional information

Niels Graudal is a member of the 2013 IOM Committee on Sodium Intake in Populations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Graudal, N. Dietary Sodium: Where Science and Policy Conflict: Impact of the 2013 IOM Report on Sodium Intake in Populations. Curr Hypertens Rep 17, 9 (2015). https://doi.org/10.1007/s11906-014-0522-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-014-0522-0

Keywords

Search

Navigation